Background and Purpose: The diverse causes of right-sided heart failure (RHF) include,
among others, primary cardiomyopathies with right ventricular (RV) involvement, RV …

Pulmonary embolism (PE) is the leading cause of in-hospital death and the third most
frequent cause of cardiovascular death. The clinical presentation of PE is variable, and …

Methods A writing group was established with representation from the Council on Peripheral
Vascular Disease and Council on Cardiopulmonary, Critical Care, Perioperative and …

The optimal N-terminal pro-brain natriuretic peptide (NT-proBNP) cut-off value for risk
stratification of pulmonary embolism remains controversial. In this study we validated and …

Background: The role of biomarkers such as B-type natriuretic peptides (BNP and NT-
proBNP) and troponins in risk stratification of acute pulmonary embolism (APE) is still …

Pulmonary embolism (PE) represents a common disease in emergency medicine and
guidelines for diagnosis and treatment have had wide diffusion. However, PE morbidity and …

Aim The aims of the study are to investigate the changes in platelet indexes, including
platelet count, platelet distribution width (PDW), and mean platelet volume (MPV), in patients …

Thrombolytic therapy accelerates the dissolution of acute pulmonary embolism and is
potentially lifesaving. The goal of this article is to offer a critical analysis of the use of …

Objective To explore disagreements in multiple systematic reviews (SRs) assessing the
benefit-to-harm ratio of thrombolytic therapy in patients with intermediate-risk pulmonary …

Background The evaluation of the role of novel biomarkers in the management of cardiac
and pulmonary conditions has received particular attention in recent years. A further …